Combination of integrin siRNA and irradiation for breast cancer therapy

Biochemical and Biophysical Research Communications

Volumn 351, Issue 3, 2006, Pages 726-732

  Cao, Qizhen ^a   Cai, Weibo ^a   Li, Tianfang ^a   Yang, Yong ^a   Chen, Kai ^a   Xing, Lei ^a   Chen, Xiaoyuan ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Combination therapy; Integrin v 3; Radiotherapy; Small interfering RNA (siRNA)

Indexed keywords

SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; EVALUATION; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; GENE SILENCING; GENE THERAPY; HUMANS; INTEGRIN ALPHAVBETA3; RADIOTHERAPY; RNA, SMALL INTERFERING; TREATMENT OUTCOME;

EID: 33750705930     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.100     Document Type: Article

References (21)

1. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
2. Hood J.D., and Cheresh D.A. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2 (2002) 91-100
3. Felding-Habermann B., O'Toole T.E., Smith J.W., Fransvea E., Ruggeri Z.M., Ginsberg M.H., Hughes P.E., Pampori N., Shattil S.J., Saven A., and Mueller B.M. Integrin activation controls metastasis in human breast cancer. Proc. Natl. Acad. Sci. USA 98 (2001) 1853-1858
4. Parthymou A., Kardamakis D., Pavlopoulos I., and Papadimitriou E. Irradiated C6 glioma cells induce angiogenesis in vivo and activate endothelial cells in vitro. Int. J. Cancer 110 (2004) 807-814
5. 3 antagonism. Anti-Cancer Agents Med. Chem. 6 (2006) 407-428
6. 3 as a therapeutic target for blocking tumor-induced angiogenesis. Curr. Drug Targets 4 (2003) 123-131
7. Qiao R., Yan W., Lum H., and Malik A.B. Arg-Gly-Asp peptide increases endothelial hydraulic conductivity: comparison with thrombin response. Am. J. Physiol. 269 (1995) C110-C117
8. 3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clin. Cancer Res. 11 (2005) 6270-6279
9. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
10. Elbashir S.M., Lendeckel W., and Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15 (2001) 188-200
11. Schiffelers R.M., Woodle M.C., and Scaria P. Pharmaceutical prospects for RNA interference. Pharm. Res. 21 (2004) 1-7
12. 3 integrin mediates virus entry into cells. J. Biol. Chem. 279 (2004) 54533-54541
13. 3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146 (2005) 2864-2871
14. 3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J. Biol. Chem. 279 (2004) 23996-24006
15. 3 integrin expression. J. Nucl. Med. 47 (2006) 1172-1180
16. Cai W., Shin D.W., Chen K., Gheysens O., Cao Q., Wang S.X., Gambhir S.S., and Chen X. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett. 6 (2006) 669-676
17. Cheresh D.A., and Spiro R.C. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J. Biol. Chem. 262 (1987) 17703-17711
18. Cordes N., and Meineke V. Integrin signalling and the cellular response to ionizing radiation. J. Mol. Histol. 35 (2004) 327-337
19. Gorski D.H., Beckett M.A., Jaskowiak N.T., Calvin D.P., Mauceri H.J., Salloum R.M., Seetharam S., Koons A., Hari D.M., Kufe D.W., and Weichselbaum R.R. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 59 (1999) 3374-3378
20. v Integrins mediate adhesion and migration of breast carcinoma cell lines. Clin. Exp. Metastasis 16 (1998) 50-61
21. Schiffelers R.M., Ansari A., Xu J., Zhou Q., Tang Q., Storm G., Molema G., Lu P.Y., Scaria P.V., and Woodle M.C. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucl. Acids Res. 32 (2004) e149